C2N Diagnostics LLC - Product Pipeline Analysis - New Market Research Report
C2N Diagnostics LLC (C2N Diagnostics) is a biotechnology company. It develops tools and assays for clinical drug development, pre-clinical drug discovery and the early detection and assessment of neurodegenerative disorders. The product portfolio of the comapny include SILK-Ab and SISAQ-Ab Assays. Theses assays utilizes stable isotope labeling and tandem mass spectrometry for the measurement of the kinetics, or in vivo metabolism, and absolute quantitation of brain derived proteins. It is also developing products to target Huntington's disease, Parkinson's disease, brain...
View full press release